Author:
Kossinna Pathum,Cai Weijia,Lu Xuewen,Shemanko Carrie S,Zhang Qingrun
Abstract
SummaryApproaches systematically characterizing interactions via transcriptomic data usually follow two systems: (1) co-expression network analyses focusing on correlations between genes; (2) linear regressions (usually regularized) to select multiple genes jointly. Both suffer from the problem of stability: a slight change of parameterization or dataset could lead to dramatic alternations of outcomes. Here, we propose Stabilized Core gene and Pathway Election, or SCOPE, a tool integrating bootstrapped LASSO and co-expression analysis, leading to robust outcomes insensitive to variations in data. By applying SCOPE to six cancer expression datasets (BRCA, COAD, KIRC, LUAD, PRAD and THCA) in The Cancer Genome Atlas, we identified core genes capturing interaction effects in crucial pan-cancer pathways related to genome instability and DNA damage response. Moreover, we highlighted the pivotal role of CD63 as an oncogenic driver and a potential therapeutic target in kidney cancer. SCOPE enables stabilized investigations towards complex interactions using transcriptome data.Availabilityhttps://github.com/QingrunZhangLab/SCOPE
Publisher
Cold Spring Harbor Laboratory
Reference65 articles.
1. DawnRank: Discovering personalized driver genes in cancer;Genome Medicine,2014
2. Comprehensive Characterization of Cancer Driver Genes and Mutations
3. Comprehensive identification of mutational cancer driver genes across 12 tumor types;Scientific Reports,2013
4. An Integrated Approach to Uncover Drivers of Cancer
5. Mutual exclusivity analysis identifies oncogenic network modules